Filtros : "GRU999QBQ" "OSTEOPOROSE" Removidos: "Tecnologia Nuclear - Materiais" " FCF003" "IFSC333" "Sociedade Brasileira de Física" Limpar

Filtros



Refine with date range


  • Source: Biomolecules. Unidade: IQ

    Subjects: OSTEOPOROSE, PEPTÍDEOS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      REIS, Thamara Gonçalves et al. Recombinant human peptide growth factors, bone morphogenetic protein-7 (rhBMP7), and platelet-derived growth factor-BB (rhPDGF-BB) for osteoporosis treatment in an oophorectomized rat model. Biomolecules, v. 14, p. 1-19 art. 317, 2024Tradução . . Disponível em: https://dx.doi.org/10.3390/biom14030317. Acesso em: 12 jul. 2024.
    • APA

      Reis, T. G., Colletto, A. M. S. D., Silva, L. A. S., Koga, B. A. A., Sogayar, M. C., & Carreira, A. C. O. (2024). Recombinant human peptide growth factors, bone morphogenetic protein-7 (rhBMP7), and platelet-derived growth factor-BB (rhPDGF-BB) for osteoporosis treatment in an oophorectomized rat model. Biomolecules, 14, 1-19 art. 317. doi:10.3390/biom14030317
    • NLM

      Reis TG, Colletto AMSD, Silva LAS, Koga BAA, Sogayar MC, Carreira ACO. Recombinant human peptide growth factors, bone morphogenetic protein-7 (rhBMP7), and platelet-derived growth factor-BB (rhPDGF-BB) for osteoporosis treatment in an oophorectomized rat model [Internet]. Biomolecules. 2024 ; 14 1-19 art. 317.[citado 2024 jul. 12 ] Available from: https://dx.doi.org/10.3390/biom14030317
    • Vancouver

      Reis TG, Colletto AMSD, Silva LAS, Koga BAA, Sogayar MC, Carreira ACO. Recombinant human peptide growth factors, bone morphogenetic protein-7 (rhBMP7), and platelet-derived growth factor-BB (rhPDGF-BB) for osteoporosis treatment in an oophorectomized rat model [Internet]. Biomolecules. 2024 ; 14 1-19 art. 317.[citado 2024 jul. 12 ] Available from: https://dx.doi.org/10.3390/biom14030317

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024